Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""positive"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-25 z 330273
Tytuł:
Asymptomatic Carriage Rate, Multidrug Resistance Level, and Associated Risk Factors of Enterococcus in Clinical Samples among HIV-Positive Patients Attending at Debre Birhan Comprehensive Specialized Hospital, North Showa, Ethiopia.
Autorzy:
Tilahun M; Department of Medical Laboratory Sciences, College of Medicine and Health Science, Wollo University, Dessie, Ethiopia.
Gedefie A; Department of Medical Laboratory Sciences, College of Medicine and Health Science, Wollo University, Dessie, Ethiopia.
Sahle Z; Department of Medical Laboratory Science, Debre Birhan Health Science College, North Showa, Ethiopia.
Pokaż więcej
Źródło:
BioMed research international [Biomed Res Int] 2023 Feb 06; Vol. 2023, pp. 7310856. Date of Electronic Publication: 2023 Feb 06 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Bacterial Infections*/drug therapy
HIV Seropositivity*
Wound Infection*/drug therapy
Gram-Positive Bacterial Infections*/complications
Gram-Positive Bacterial Infections*/drug therapy
Gram-Positive Bacterial Infections*/epidemiology
Humans ; Enterococcus ; Ethiopia/epidemiology ; Cross-Sectional Studies ; Microbial Sensitivity Tests ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Risk Factors ; Drug Resistance, Multiple, Bacterial ; Gram-Positive Bacteria ; Hospitals
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Brucella Species Staining as Gram-Positive Rod and Gram-Positive Cocci in Chains.
Autorzy:
Baykara Y; Microbiology Laboratory, Department of Pathology and Laboratory Medicine, The Miriam Hospital and Rhode Island Hospital, Providence, Rhode Island.
Trapassi C; Microbiology Laboratory, Department of Pathology and Laboratory Medicine, The Miriam Hospital and Rhode Island Hospital, Providence, Rhode Island.
Miceli G; Microbiology Laboratory, Department of Pathology and Laboratory Medicine, The Miriam Hospital and Rhode Island Hospital, Providence, Rhode Island.
Bouchard C; Microbiology Laboratory, Department of Pathology and Laboratory Medicine, The Miriam Hospital and Rhode Island Hospital, Providence, Rhode Island.
Bilida S; Microbiology Laboratory, Department of Pathology and Laboratory Medicine, The Miriam Hospital and Rhode Island Hospital, Providence, Rhode Island.
Lonks JR; Division of Infectious Diseases, The Miriam Hospital and Rhode Island Hospital, Providence, Rhode Island.
Mileno M; Division of Infectious Diseases, The Miriam Hospital and Rhode Island Hospital, Providence, Rhode Island.
Radhakrishnan P; Division of Infectious Diseases, The Miriam Hospital and Rhode Island Hospital, Providence, Rhode Island.
Whitehead V; Microbiology Laboratory, Department of Pathology and Laboratory Medicine, The Miriam Hospital and Rhode Island Hospital, Providence, Rhode Island.
Hong T; Microbiology Laboratory, Department of Pathology and Laboratory Medicine, The Miriam Hospital and Rhode Island Hospital, Providence, Rhode Island.
Pokaż więcej
Źródło:
Rhode Island medical journal (2013) [R I Med J (2013)] 2022 Nov 01; Vol. 105 (9), pp. 34-36. Date of Electronic Publication: 2022 Nov 01.
Typ publikacji:
Journal Article
MeSH Terms:
Gram-Positive Cocci*
Brucella*
Humans ; Gram-Positive Rods ; Bacteria ; Staining and Labeling
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Unveiling IL6R and MYC as Targeting Biomarkers in Imatinib-Resistant Chronic Myeloid Leukemia through Advanced Non-Invasive Apoptosis Detection Sensor Version 2 Detection.
Autorzy:
Lee CH; School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, New Taipei City 23561, Taiwan.; Ph.D. Program in Medicine Biotechnology, College of Medical Science and Technology, Taipei Medical University, New Taipei City 23561, Taiwan.; TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan.; Center for Intelligent Drug Systems and Smart Bio-Devices (IDS2B), National Yang Ming Chiao Tung University, Hsinchu 30068, Taiwan.
Hsu KW; Research Center for Cancer Biology, China Medical University, Taichung City 40402, Taiwan.; Institute of Translational Medicine and New Drug Development, China Medical University, Taichung City 40402, Taiwan.; Program for Cancer Biology and Drug Discovery, Drug Development Center, China Medical University, Taichung City 40402, Taiwan.
Hsieh YY; Division of Hematology and Oncology, Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan.; Division of Hematology and Oncology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.
Li WT; Department of Physiology, UT Southwestern Medical Center, Dallas, TX 75390, USA.
Long Y; Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.; Chinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford OX3 7BN, UK.
Lin CY; Center for Intelligent Drug Systems and Smart Bio-Devices (IDS2B), National Yang Ming Chiao Tung University, Hsinchu 30068, Taiwan.; Institute of Bioinformatics and Systems Biology, National Yang Ming Chiao Tung University, Hsinchu 30068, Taiwan.; School of Dentistry, Kaohsiung Medical University, Kaohsiung 807378, Taiwan.
Chen SH; Department of Pediatrics, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.; Department of Pediatrics, Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan.
Pokaż więcej
Źródło:
Cells [Cells] 2024 Apr 02; Vol. 13 (7). Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:
Journal Article
MeSH Terms:
Protein Kinase Inhibitors*/pharmacology
Protein Kinase Inhibitors*/therapeutic use
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/pathology
Humans ; Imatinib Mesylate/pharmacology ; Imatinib Mesylate/therapeutic use ; Drug Resistance, Neoplasm ; Apoptosis ; Biomarkers ; Receptors, Interleukin-6
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Promiscuous, persistent and problematic: insights into current enterococcal genomics to guide therapeutic strategy.
Autorzy:
Hourigan D; APC Microbiome Ireland, Biosciences Institute, Biosciences Research Institute, College Rd, University College, Cork, Ireland.; School of Microbiology, University College Cork, College Rd, University College, Cork, Ireland.
Stefanovic E; APC Microbiome Ireland, Biosciences Institute, Biosciences Research Institute, College Rd, University College, Cork, Ireland.; Teagasc Food Research Centre, Moorepark, Moorepark West, Fermoy, Co. Cork, Ireland.
Hill C; APC Microbiome Ireland, Biosciences Institute, Biosciences Research Institute, College Rd, University College, Cork, Ireland.; School of Microbiology, University College Cork, College Rd, University College, Cork, Ireland.
Ross RP; APC Microbiome Ireland, Biosciences Institute, Biosciences Research Institute, College Rd, University College, Cork, Ireland. .; School of Microbiology, University College Cork, College Rd, University College, Cork, Ireland. .; Teagasc Food Research Centre, Moorepark, Moorepark West, Fermoy, Co. Cork, Ireland. .
Pokaż więcej
Źródło:
BMC microbiology [BMC Microbiol] 2024 Mar 28; Vol. 24 (1), pp. 103. Date of Electronic Publication: 2024 Mar 28.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Vancomycin-Resistant Enterococci*/genetics
Enterococcus faecium*/genetics
Gastrointestinal Microbiome*/genetics
Gram-Positive Bacterial Infections*/drug therapy
Gram-Positive Bacterial Infections*/microbiology
Humans ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Genomics ; Microbial Sensitivity Tests
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
FL118 Is a Potent Therapeutic Agent against Chronic Myeloid Leukemia Resistant to BCR-ABL Inhibitors through Targeting RNA Helicase DDX5.
Autorzy:
Takeda K; Division of Hygienic Chemistry, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan.
Ohta S; Division of Structural Biochemistry, Department of Biochemistry, School of Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke-shi 329-0498, Tochigi, Japan.
Nagao M; Division of Hygienic Chemistry, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan.
Kobayashi E; Division of Hygienic Chemistry, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan.
Tago K; Department of Laboratory Sciences, Gunma University Graduate School of Health Sciences, 3-39-22 Showa-Machi, Maebashi 371-8514, Gunma, Japan.
Funakoshi-Tago M; Division of Hygienic Chemistry, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 26; Vol. 25 (7). Date of Electronic Publication: 2024 Mar 26.
Typ publikacji:
Journal Article
MeSH Terms:
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/genetics
Leukemia, Myeloid*
Indolizines*
Humans ; Benzodioxoles ; Protein Kinase Inhibitors/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Screening of microRNAs in Chronic Myeloid Leukemia: A Clinical Evaluation.
Autorzy:
Wosniaki DK; Laboratory for Applied Science and Technology in Health, Carlos Chagas Institute, Oswaldo Cruz Foundation (Fiocruz), Curitiba 81350-010, Brazil.
Marin AM; Laboratory for Applied Science and Technology in Health, Carlos Chagas Institute, Oswaldo Cruz Foundation (Fiocruz), Curitiba 81350-010, Brazil.
Oliveira RN; Laboratory for Applied Science and Technology in Health, Carlos Chagas Institute, Oswaldo Cruz Foundation (Fiocruz), Curitiba 81350-010, Brazil.
Koerich GM; Laboratory for Applied Science and Technology in Health, Carlos Chagas Institute, Oswaldo Cruz Foundation (Fiocruz), Curitiba 81350-010, Brazil.
Munhoz EC; Erasto Gaertner Hospital, Curitiba 81520-060, Brazil.
Farias JSH; Erasto Gaertner Hospital, Curitiba 81520-060, Brazil.
Beltrame MP; Erasto Gaertner Hospital, Curitiba 81520-060, Brazil.
Zanette DL; Laboratory for Applied Science and Technology in Health, Carlos Chagas Institute, Oswaldo Cruz Foundation (Fiocruz), Curitiba 81350-010, Brazil.
Aoki MN; Laboratory for Applied Science and Technology in Health, Carlos Chagas Institute, Oswaldo Cruz Foundation (Fiocruz), Curitiba 81350-010, Brazil.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 16; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 16.
Typ publikacji:
Journal Article
MeSH Terms:
MicroRNAs*/genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/diagnosis
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/pathology
Humans ; Fusion Proteins, bcr-abl/genetics ; Fusion Proteins, bcr-abl/metabolism ; Translocation, Genetic ; Biomarkers
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical Insights into Structure, Regulation, and Targeting of ABL Kinases in Human Leukemia.
Autorzy:
Wu A; Collings Stevens Chronic Leukemia Research Laboratory, Terry Fox Laboratory, British Columbia Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada.; Department of Medicine, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
Liu X; Collings Stevens Chronic Leukemia Research Laboratory, Terry Fox Laboratory, British Columbia Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada.; Department of Medicine, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
Fruhstorfer C; Collings Stevens Chronic Leukemia Research Laboratory, Terry Fox Laboratory, British Columbia Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada.
Jiang X; Collings Stevens Chronic Leukemia Research Laboratory, Terry Fox Laboratory, British Columbia Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada.; Department of Medicine, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 14; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:
Journal Article; Systematic Review
MeSH Terms:
Fusion Proteins, bcr-abl*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/metabolism
Humans ; Drug Resistance, Neoplasm/genetics ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Signal Transduction
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Interactions of Gram-Positive Bacterial Membrane Vesicles and Hosts: Updates and Future Directions.
Autorzy:
Sangiorgio G; Department of Biomedical and Biotechnological Sciences (BIOMETEC), University of Catania, 95125 Catania, Italy.
Nicitra E; Department of Biomedical and Biotechnological Sciences (BIOMETEC), University of Catania, 95125 Catania, Italy.
Bivona D; Department of Biomedical and Biotechnological Sciences (BIOMETEC), University of Catania, 95125 Catania, Italy.
Bonomo C; Department of Biomedical and Biotechnological Sciences (BIOMETEC), University of Catania, 95125 Catania, Italy.
Bonacci P; Department of Biomedical and Biotechnological Sciences (BIOMETEC), University of Catania, 95125 Catania, Italy.
Santagati M; Department of Biomedical and Biotechnological Sciences (BIOMETEC), University of Catania, 95125 Catania, Italy.
Musso N; Department of Biomedical and Biotechnological Sciences (BIOMETEC), University of Catania, 95125 Catania, Italy.
Bongiorno D; Department of Biomedical and Biotechnological Sciences (BIOMETEC), University of Catania, 95125 Catania, Italy.
Stefani S; Department of Biomedical and Biotechnological Sciences (BIOMETEC), University of Catania, 95125 Catania, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 01; Vol. 25 (5). Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Gram-Positive Bacteria*
Extracellular Vesicles*/metabolism
Bacteria ; Membranes ; Cell Membrane ; Lipid Bilayers/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Nilotinib-Associated Multiple Silent Arterial Stenoses in a Patient with Chronic Myeloid Leukemia
Autorzy:
Tokatlı M; Hacettepe University Faculty of Medicine, Department of Internal Medicine, Ankara, Türkiye
Ismayilov R; Hacettepe University Faculty of Medicine, Department of Internal Medicine, Ankara, Türkiye
Erkin Çınar O; Hacettepe University Faculty of Medicine, Department of Hematology, Ankara, Türkiye
Haznedaroğlu İC; Hacettepe University Faculty of Medicine, Department of Hematology, Ankara, Türkiye
Pokaż więcej
Źródło:
Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2024 Mar 01; Vol. 41 (1), pp. 59-60. Date of Electronic Publication: 2023 Dec 28.
Typ publikacji:
Journal Article
MeSH Terms:
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/complications
Leukemia, Myeloid*/complications
Antineoplastic Agents*/adverse effects
Leukemia, Myeloid, Chronic-Phase*/complications
Humans ; Constriction, Pathologic/complications ; Pyrimidines/adverse effects ; Protein Kinase Inhibitors/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Comparison of the effects of open and closed aspiration on end-expiratory lung volume in acute respiratory distress syndrome.
Autorzy:
Yildirim S; Intensive Care Unit, University of Health Sciences Turkey, İzmir School of Medicine, Dr. Suat Seren Chest Disease and Surgery Training and Research Hospital, İzmir, Turkey.
Saygili SM; Intensive Care Unit, University of Health Sciences Turkey, İzmir School of Medicine, Dr. Suat Seren Chest Disease and Surgery Training and Research Hospital, İzmir, Turkey.
Süneçli O; Department of Physiotherapy, University of Health Sciences Turkey, İzmir School of Medicine, Dr. Suat Seren Chest Disease and Surgery Training and Research Hospital, İzmir, Turkey.
Kirakli C; Intensive Care Unit, University of Health Sciences Turkey, İzmir School of Medicine, Dr. Suat Seren Chest Disease and Surgery Training and Research Hospital, İzmir, Turkey.
Pokaż więcej
Źródło:
Korean journal of anesthesiology [Korean J Anesthesiol] 2024 Feb; Vol. 77 (1), pp. 115-121. Date of Electronic Publication: 2023 May 22.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Positive-Pressure Respiration*/methods
Respiratory Distress Syndrome*/therapy
Humans ; Cross-Over Studies ; Lung Volume Measurements ; Respiration, Artificial/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
First reported human case of isolation of Vagococcus fluvialis from the urine of a former zoo clerk in Japan: a case report.
Autorzy:
Kitano H; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 734-8551, Hiroshima, Japan. .
Kitagawa H; Department of Infectious Diseases, Hiroshima University Hospital, 734-8551, Hiroshima, Japan.
Tadera K; Department of Clinical Practice and Support, Hiroshima University Hospital, 734-8551, Hiroshima, Japan.
Saito K; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 734-8551, Hiroshima, Japan.
Kohada Y; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 734-8551, Hiroshima, Japan.
Takemoto K; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 734-8551, Hiroshima, Japan.
Kobatake K; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 734-8551, Hiroshima, Japan.
Sekino Y; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 734-8551, Hiroshima, Japan.
Hieda K; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 734-8551, Hiroshima, Japan.
Ohge H; Department of Clinical Practice and Support, Hiroshima University Hospital, 734-8551, Hiroshima, Japan.
Hinata N; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 734-8551, Hiroshima, Japan.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Mar 21; Vol. 24 (1), pp. 341. Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Gram-Positive Cocci*
Urinary Tract Infections*/microbiology
Aged, 80 and over ; Humans ; Male ; Enterococcaceae ; Japan ; Levofloxacin ; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods
SCR Organism:
Vagococcus fluvialis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Protective effect of microbisporicin (NAI-107) against vancomycin resistant Enterococcus faecium infection in a Galleria mellonella model.
Autorzy:
Hofkens N; Department of Clinical Sciences, Institute of Tropical Medicine Antwerp, 2000, Antwerp, Belgium.
Gestels Z; Department of Clinical Sciences, Institute of Tropical Medicine Antwerp, 2000, Antwerp, Belgium.
Abdellati S; Clinical Reference Laboratory, Department of Clinical Sciences, Institute of Tropical Medicine, 2000, Antwerp, Belgium.
Gabant P; Syngulon, Seraing, Belgium.
Rodriguez-Villalobos H; Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, 1200, Brussels, Belgium.
Martin A; Syngulon, Seraing, Belgium.
Kenyon C; Department of Clinical Sciences, Institute of Tropical Medicine Antwerp, 2000, Antwerp, Belgium.; Department of Medicine, University of Cape Town, Cape Town, 7700, South Africa.
Manoharan-Basil SS; Department of Clinical Sciences, Institute of Tropical Medicine Antwerp, 2000, Antwerp, Belgium. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 27; Vol. 14 (1), pp. 4786. Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:
Journal Article
MeSH Terms:
Enterococcus faecium*
Bacteriocins*/pharmacology
Moths*
Vancomycin-Resistant Enterococci*
Gram-Positive Bacterial Infections*/drug therapy
Animals ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Vancomycin/pharmacology ; Microbial Sensitivity Tests
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Vagococcus fluvialis isolation from the urine of a bladder cancer patient: a case report.
Autorzy:
Chen Q; Department of Surgery, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, 410005, Changsha, Hunan, P.R. China.
Tan S; Department of Comprehensive Surgery, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, 410005, Changsha, Hunan, P.R. China.
Long S; Department of Clinical Laboratory, Hunan Province People's Hospital, The First Affiliated Hospital of Hunan Normal University, 410005, Changsha, Hunan, P.R. China.
Wang K; Department of Comprehensive Surgery, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, 410005, Changsha, Hunan, P.R. China.
Liu Q; Department of Comprehensive Surgery, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, 410005, Changsha, Hunan, P.R. China. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Feb 26; Vol. 24 (1), pp. 261. Date of Electronic Publication: 2024 Feb 26.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Gram-Positive Cocci*
Urinary Bladder Neoplasms*
Humans ; Vancomycin ; Microbial Sensitivity Tests ; Enterococcaceae ; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods
SCR Organism:
Vagococcus fluvialis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Epidemiology and infection control of vancomycin-resistant enterococci at a German university hospital: A three-year retrospective cohort study.
Autorzy:
Jochim-Vukosavic A; Hannover Medical School, Institute for Medical Microbiology and Hospital Epidemiology, Hannover, Germany.
Schwab F; Institute of Hygiene and Environmental Medicine, Charité-University Medicine, Berlin, Germany.
Knegendorf L; Hannover Medical School, Institute for Medical Microbiology and Hospital Epidemiology, Hannover, Germany.
Schlüter D; Hannover Medical School, Institute for Medical Microbiology and Hospital Epidemiology, Hannover, Germany.
Bange FC; Hannover Medical School, Institute for Medical Microbiology and Hospital Epidemiology, Hannover, Germany.
Ebadi E; Hannover Medical School, Institute for Medical Microbiology and Hospital Epidemiology, Hannover, Germany.
Baier C; Hannover Medical School, Institute for Medical Microbiology and Hospital Epidemiology, Hannover, Germany.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Feb 26; Vol. 19 (2), pp. e0297866. Date of Electronic Publication: 2024 Feb 26 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Vancomycin-Resistant Enterococci*/genetics
Cross Infection*/epidemiology
Gram-Positive Bacterial Infections*/epidemiology
Enterococcus faecium*
Humans ; Hospitals, University ; Retrospective Studies ; Infection Control ; Anti-Bacterial Agents
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
From the Friend to the Foe- Enterococcus faecalis Diverse Impact on the Human Immune System.
Autorzy:
Daca A; Department of Physiopathology, Medical University of Gdańsk, 80-210 Gdańsk, Poland.
Jarzembowski T; Department of Microbiology, Medical University of Gdańsk, 80-210 Gdańsk, Poland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 19; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 19.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Enterococcus faecalis*/metabolism
Gram-Positive Bacterial Infections*/microbiology
Humans ; Friends ; Virulence ; Virulence Factors/metabolism ; Immune System/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Inhibition of LATS kinases reduces tumorigenicity and increases the sensitivity of human chronic myelogenous leukemia cells to imatinib.
Autorzy:
Klaihmon P; Siriraj Center of Excellence for Stem Cell Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Lorthongpanich C; Siriraj Center of Excellence for Stem Cell Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. .; Blood Products and Cellular Immunotherapy Research Group, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand. .
Kheolamai P; Center of Excellence in Stem Cell Research and Innovations, Division of Cell Biology, Faculty of Medicine, Thammasat University, Pathumthani, Thailand. .
Saisaard W; Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Issaragrisil S; Siriraj Center of Excellence for Stem Cell Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.; Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 18; Vol. 14 (1), pp. 3993. Date of Electronic Publication: 2024 Feb 18.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Resistance, Neoplasm*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/pathology
Humans ; Imatinib Mesylate/pharmacology ; Imatinib Mesylate/therapeutic use ; Fusion Proteins, bcr-abl/genetics ; Protein Serine-Threonine Kinases ; K562 Cells ; Apoptosis ; Tumor Suppressor Proteins
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Adaptation and validation of a quantitative vanA/vanB DNA screening assay on a high-throughput PCR system.
Autorzy:
Giersch K; Institute of Medical Microbiology, Virology and Hygiene, University Medical Centre Hamburg-Eppendorf (UKE), Martinistraße 52, 20246, Hamburg, Germany.
Tanida K; Institute of Medical Microbiology, Virology and Hygiene, University Medical Centre Hamburg-Eppendorf (UKE), Martinistraße 52, 20246, Hamburg, Germany.
Both A; Institute of Medical Microbiology, Virology and Hygiene, University Medical Centre Hamburg-Eppendorf (UKE), Martinistraße 52, 20246, Hamburg, Germany.
Nörz D; Institute of Medical Microbiology, Virology and Hygiene, University Medical Centre Hamburg-Eppendorf (UKE), Martinistraße 52, 20246, Hamburg, Germany.
Heim D; Institute of Medical Microbiology, Virology and Hygiene, University Medical Centre Hamburg-Eppendorf (UKE), Martinistraße 52, 20246, Hamburg, Germany.
Rohde H; Institute of Medical Microbiology, Virology and Hygiene, University Medical Centre Hamburg-Eppendorf (UKE), Martinistraße 52, 20246, Hamburg, Germany.
Aepfelbacher M; Institute of Medical Microbiology, Virology and Hygiene, University Medical Centre Hamburg-Eppendorf (UKE), Martinistraße 52, 20246, Hamburg, Germany.
Lütgehetmann M; Institute of Medical Microbiology, Virology and Hygiene, University Medical Centre Hamburg-Eppendorf (UKE), Martinistraße 52, 20246, Hamburg, Germany. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 12; Vol. 14 (1), pp. 3523. Date of Electronic Publication: 2024 Feb 12.
Typ publikacji:
Journal Article
MeSH Terms:
Vancomycin-Resistant Enterococci*/genetics
Gram-Positive Bacterial Infections*/microbiology
Humans ; Predictive Value of Tests ; Real-Time Polymerase Chain Reaction ; DNA ; DNA, Bacterial/genetics ; DNA, Bacterial/analysis ; Bacterial Proteins/genetics ; Anti-Bacterial Agents
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
To treat or not to treat: Assessing the role of anti-enterococcal therapy for intra-abdominal infections in patients with cancer.
Autorzy:
Akazawa N; Division of Infectious Diseases, Shizuoka Cancer Center, Sunto-gun, Shizuoka, Japan.; Division of Infectious Diseases, Aichi Cancer Center, Nagoya, Japan.
Itoh N; Division of Infectious Diseases, Aichi Cancer Center, Nagoya, Japan.
Mano-Usui F; General Incorporated Association Kansai Healthcare Science Informatics, Kyoto, Japan.
Tatsuoka H; General Incorporated Association Kansai Healthcare Science Informatics, Kyoto, Japan.; Yutaka Seino Distinguished Center for Diabetes Research, Kansai Electric Power Medical Research Institute, Kobe, Japan.
Terada N; Department of Infectious Diseases, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.; Division of Infectious Diseases, Department of Medicine, Tsukuba Medical Center Hospital, Tsukuba, Ibaraki, Japan.
Kurai H; Division of Infectious Diseases, Shizuoka Cancer Center, Sunto-gun, Shizuoka, Japan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Feb 07; Vol. 19 (2), pp. e0298018. Date of Electronic Publication: 2024 Feb 07 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Gram-Positive Bacterial Infections*/drug therapy
Anti-Infective Agents*/therapeutic use
Intraabdominal Infections*/complications
Intraabdominal Infections*/drug therapy
Neoplasms*/complications
Neoplasms*/drug therapy
Humans ; Adult ; Anti-Bacterial Agents/therapeutic use ; Retrospective Studies ; Prospective Studies ; Enterococcus
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Dolosigranulum pigrum: A promising nasal probiotic candidate.
Autorzy:
Stubbendieck RM; Department of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, Oklahoma, United States of America.
Hurst JH; Department of Pediatrics, Division of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina, United States of America.; Children's Health and Discovery Institute, Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, United States of America.
Kelly MS; Department of Pediatrics, Division of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina, United States of America.; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, North Carolina, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2024 Feb 01; Vol. 20 (2), pp. e1011955. Date of Electronic Publication: 2024 Feb 01 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Gram-Positive Cocci*
Carnobacteriaceae*
SCR Organism:
Dolosigranulum pigrum
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Combination of venetoclax with BCR-ABL tyrosine kinase inhibitor as a therapeutic strategy for Philadelphia chromosome-positive leukemias.
Autorzy:
Zou JY; Suzhou Vocational Health College, Suzhou, People's Republic of China.
Huang SM; Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, People's Republic of China.
Zhoub HX; Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, People's Republic of China.
Xu MZ; Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, People's Republic of China.
Sun AN; Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, People's Republic of China.
Wu DP; Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, People's Republic of China.
Xue SL; Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, People's Republic of China.
Zhang TT; Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, People's Republic of China.
Pokaż więcej
Źródło:
Hematology (Amsterdam, Netherlands) [Hematology] 2023 Dec; Vol. 28 (1), pp. 2237790.
Typ publikacji:
Journal Article
MeSH Terms:
Philadelphia Chromosome*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/genetics
Humans ; Tyrosine Kinase Inhibitors ; Retrospective Studies ; Fusion Proteins, bcr-abl/genetics ; Protein Kinase Inhibitors/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Erythroid variant evolving from chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitors: a rare case report.
Autorzy:
Lee MH; Department of Medical Oncology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA.
Song A; Department of Internal Medicine, Columbia University Irving Medical Center, 622 W 168th Street, New York, NY, 100032, USA.
Li JY; Department of Hematopathology and Lab Medicines, H. Lee Moffitt Cancer Center & Research Institute, 12902 USF Magnolia Drive, Tampa, FL, 33612, USA. .
Pokaż więcej
Źródło:
Diagnostic pathology [Diagn Pathol] 2024 Jan 24; Vol. 19 (1), pp. 21. Date of Electronic Publication: 2024 Jan 24.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/diagnosis
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/genetics
Leukemia, Myeloid*
Bone Marrow Diseases*
Female ; Humans ; Adult ; Tyrosine Kinase Inhibitors ; Hyperplasia ; Biopsy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Bioinformatic analysis of the expression profile and identification of RhoGDI2 as a biomarker in imatinib-resistant K562 cells.
Autorzy:
Yang Y; Jiangxi Province Key Laboratory of Laboratory Medicine, Jiangxi Provincial Clinical Research Center for Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.; School of Public Health, Nanchang University, Nanchang, People's Republic of China.
Zhong F; Jiangxi Province Key Laboratory of Laboratory Medicine, Jiangxi Provincial Clinical Research Center for Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
Jiang J; Jiangxi Province Key Laboratory of Laboratory Medicine, Jiangxi Provincial Clinical Research Center for Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
Li M; Jiangxi Province Key Laboratory of Laboratory Medicine, Jiangxi Provincial Clinical Research Center for Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
Yao F; Jiangxi Province Key Laboratory of Laboratory Medicine, Jiangxi Provincial Clinical Research Center for Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
Liu J; Jiangxi Province Key Laboratory of Laboratory Medicine, Jiangxi Provincial Clinical Research Center for Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
Cheng Y; Jiangxi Province Key Laboratory of Laboratory Medicine, Jiangxi Provincial Clinical Research Center for Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.; School of Public Health, Nanchang University, Nanchang, People's Republic of China.
Xu S; Jiangxi Province Key Laboratory of Laboratory Medicine, Jiangxi Provincial Clinical Research Center for Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.; School of Public Health, Nanchang University, Nanchang, People's Republic of China.
Chen S; Jiangxi Province Key Laboratory of Laboratory Medicine, Jiangxi Provincial Clinical Research Center for Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.; School of Public Health, Nanchang University, Nanchang, People's Republic of China.
Zhang H; Jiangxi Province Key Laboratory of Laboratory Medicine, Jiangxi Provincial Clinical Research Center for Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
Xu Y; Jiangxi Province Key Laboratory of Laboratory Medicine, Jiangxi Provincial Clinical Research Center for Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
Huang B; Jiangxi Province Key Laboratory of Laboratory Medicine, Jiangxi Provincial Clinical Research Center for Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
Pokaż więcej
Źródło:
Hematology (Amsterdam, Netherlands) [Hematology] 2023 Dec; Vol. 28 (1), pp. 2244856.
Typ publikacji:
Journal Article
MeSH Terms:
MicroRNAs*/genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/genetics
Humans ; Imatinib Mesylate/pharmacology ; Imatinib Mesylate/therapeutic use ; rho Guanine Nucleotide Dissociation Inhibitor beta ; K562 Cells ; rho-Specific Guanine Nucleotide Dissociation Inhibitors ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Biomarkers ; Computational Biology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Dual inhibition of STAT3 and STAT5 may overcome imatinib resistance in chronic myeloid leukemia.
Autorzy:
Yin L; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People's Republic of China.; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, People's Republic of China.; Key Laboratory of Bone Marrow Stem Cells, Xuzhou, People's Republic of China.
Xu J; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, People's Republic of China.; Key Laboratory of Bone Marrow Stem Cells, Xuzhou, People's Republic of China.
Wu W; Medical Record and Statistical Office, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People's Republic of China.
Niu M; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People's Republic of China.; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, People's Republic of China.; Key Laboratory of Bone Marrow Stem Cells, Xuzhou, People's Republic of China.
Li Z; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People's Republic of China.; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, People's Republic of China.; Key Laboratory of Bone Marrow Stem Cells, Xuzhou, People's Republic of China.
Zhu F; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People's Republic of China.; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, People's Republic of China.; Key Laboratory of Bone Marrow Stem Cells, Xuzhou, People's Republic of China.
Xu K; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People's Republic of China.; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, People's Republic of China.; Key Laboratory of Bone Marrow Stem Cells, Xuzhou, People's Republic of China.
Pokaż więcej
Źródło:
Hematology (Amsterdam, Netherlands) [Hematology] 2023 Dec; Vol. 28 (1), pp. 2224625.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/pathology
Humans ; Imatinib Mesylate/pharmacology ; Imatinib Mesylate/therapeutic use ; STAT5 Transcription Factor/genetics ; STAT5 Transcription Factor/metabolism ; Drug Resistance, Neoplasm/genetics ; Apoptosis ; K562 Cells ; Fusion Proteins, bcr-abl/genetics ; Fusion Proteins, bcr-abl/metabolism ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; STAT3 Transcription Factor/genetics ; STAT3 Transcription Factor/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Discovery of 3-((3-amino- 1H -indazol-4-yl)ethynyl)- N -(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide (AKE-72), a potent Pan-BCR-ABL inhibitor including the T315I gatekeeper resistant mutant.
Autorzy:
El-Damasy AK; Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea.; Department of Medicinal Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
Kim HJ; Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea.
Park JW; Supercomputing Application Center, Div. of National Supercomputing, Korea Institute of Science and Technology Information, Daejeon, Republic of Korea.
Nam Y; Medicinal Materials Research Center, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea.
Hur W; Medicinal Materials Research Center, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea.
Bang EK; Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea.
Keum G; Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea.; Division of Bio-Medical Science & Technology, KIST School, Korea University of Science and Technology (UST), Seoul, Republic of Korea.
Pokaż więcej
Źródło:
Journal of enzyme inhibition and medicinal chemistry [J Enzyme Inhib Med Chem] 2023 Dec; Vol. 38 (1), pp. 2228515.
Typ publikacji:
Journal Article
MeSH Terms:
Indazoles*/pharmacology
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/metabolism
Humans ; Drug Resistance, Neoplasm ; Imatinib Mesylate/pharmacology ; Imatinib Mesylate/therapeutic use ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Fusion Proteins, bcr-abl/genetics ; Fusion Proteins, bcr-abl/metabolism ; Benzamides/pharmacology ; Cell Line, Tumor ; Mutation ; Cell Proliferation ; Apoptosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-25 z 330273

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies